AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23597479 — intervention group
Group type: COMPARATOR
Intervention: Copeptin measurement on admission
Number of subjects: 850
Study 23597479 — intervention group
Group type: COMPARATOR
Intervention: NTproBNP measurement on admission
Number of subjects: 850
Study 21798501 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 9113
Study 19459015 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery programs
Number of subjects: 4
Study 19459015 — intervention group
Group type: COMPARATOR
Intervention: Traditional postoperative care
Number of subjects: 4
Study 16809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.8 mg intravenous bolus)
Number of subjects: 0
Study 16809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (2-4 mg given over 30 min)
Number of subjects: 0
Study 16809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (2-3 mg bolus followed by continuous infusion of 4 mg/h)
Number of subjects: 0
Study 16809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (5 mg or greater)
Number of subjects: 0
Study 12832434 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (BRTr)
Number of subjects: 12
Study 12832434 — intervention group
Group type: COMPARATOR
Intervention: Control (BRCon)
Number of subjects: 12
Study 10836723 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term exercise (42-km marathon)
Number of subjects: 0
Study 10836723 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term exercise (15-km race)
Number of subjects: 0
Study 10836723 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise on a treadmill for CAD patients (30 min at 80% of maximal heart rate)
Number of subjects: 0
Study 10836723 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week cardiac rehabilitation program for CAD patients
Number of subjects: 0
Study 10836723 — intervention group
Group type: COMPARATOR
Intervention: Basal urinary excretion of cGMP in highly trained runners, sedentary subjects, and CAD patients
Number of subjects: 0
Study 10836723 — intervention group
Group type: COMPARATOR
Intervention: Basal levels of cGMP in CAD patients after 12-week cardiac rehabilitation
Number of subjects: 0
Study 9180622 — intervention group
Group type: EXPERIMENTAL
Intervention: Active biofeedback treatment
Number of subjects: 56
Study 9180622 — intervention group
Group type: COMPARATOR
Intervention: Placebo biofeedback treatment
Number of subjects: 56
Study 8256752 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 0
Study 2579879 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propafenone 300 mg t.i.d.
Number of subjects: 31
Study 2579879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propafenone 1.5 mg/kg in three minutes.
Number of subjects: 31
Study 2579879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30690595 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung lavage with diluted porcine surfactant (30 ml/kg)
Number of subjects: 33
Study 30690595 — intervention group
Group type: COMPARATOR
Intervention: Bolus surfactant (100 mg/kg)
Number of subjects: 33
Study 29894840 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective SWS suppression during night sleep
Number of subjects: 12
Study 29894840 — intervention group
Group type: COMPARATOR
Intervention: Regular night sleep (control)
Number of subjects: 12
Study 27045451 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental visual imagery (MVI) programme
Number of subjects: 17
Study 27045451 — intervention group
Group type: COMPARATOR
Intervention: Verbal control programme
Number of subjects: 17
Study 24755958 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (37.5 mg/d) in combination with docetaxel (75 mg/m2)
Number of subjects: 27
Study 24755958 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 27
Study 24755958 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib/docetaxel
Number of subjects: 27
Study 23234575 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking and Behavioural intervention (WB)
Number of subjects: 222
Study 23234575 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention (W)
Number of subjects: 222
Study 23234575 — intervention group
Group type: COMPARATOR
Intervention: Self‐directed control (C)
Number of subjects: 222
Study 19734030 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate emphysema (ES910) with apical distribution
Number of subjects: 875
Study 19734030 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe emphysema (ES950) with apical distribution
Number of subjects: 875
Study 18276127 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (algal DHA-rich oil)
Number of subjects: 17
Study 18276127 — intervention group
Group type: COMPARATOR
Intervention: Sunflower seed oil (control)
Number of subjects: 17
Study 15558238 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 361
Study 15558238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361
Study 12063368 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization
Number of subjects: 453
Study 10474062 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of DUP 996
Number of subjects: 38
Study 10474062 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of DUP 996
Number of subjects: 38
Study 10474062 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of DUP 996
Number of subjects: 38
Study 10474062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 8607407 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg)
Number of subjects: 48
Study 8607407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 1708214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamorphone 0.24 micrograms/kg
Number of subjects: 72
Study 1708214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamorphone 0.16 micrograms/kg
Number of subjects: 72
Study 1708214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamorphone 0.08 micrograms/kg
Number of subjects: 72
Study 1708214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 6136691 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline irrigation via a special dressing
Number of subjects: 12
Study 6136691 — intervention group
Group type: COMPARATOR
Intervention: Conventional saline dressings
Number of subjects: 12
Study 30667189 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish
Number of subjects: 0
Study 30667189 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant
Number of subjects: 0
Study 28325960 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol-Codeine (analgesic group)
Number of subjects: 32
Study 28325960 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 32
Study 26747845 — intervention group
Group type: EXPERIMENTAL
Intervention: web‐based TF‐CBT training + consultation (W)
Number of subjects: 129
Study 26747845 — intervention group
Group type: EXPERIMENTAL
Intervention: W + 2 day live TF‐CBT workshop + twice monthly phone consultation (W + L)
Number of subjects: 129
Study 26747845 — intervention group
Group type: EXPERIMENTAL
Intervention: TF‐CBT (across conditions)
Number of subjects: 129
Study 24368034 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplitude-modulated stimulus (AM-SSVEP)
Number of subjects: 0
Study 24368034 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency SSVEP
Number of subjects: 0
Study 24368034 — intervention group
Group type: COMPARATOR
Intervention: High-frequency SSVEP
Number of subjects: 0
Study 22971521 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 repeat intradermal injections of grass pollen extract (7 ng of Phl p 5 per injection) at 2-week intervals
Number of subjects: 30
Study 22971521 — intervention group
Group type: COMPARATOR
Intervention: 2 intradermal injections separated by 10 weeks
Number of subjects: 30
Study 22971521 — intervention group
Group type: COMPARATOR
Intervention: A single intradermal injection at 10 weeks
Number of subjects: 30
Study 19397752 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. dexamethasone (0.5 mg/kg)
Number of subjects: 41
Study 19397752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 19397752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study 17599563 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 72
Study 15179544 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day, orally)
Number of subjects: 8
Study 11251702 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g intravenous magnesium sulfate
Number of subjects: 30
Study 11251702 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of 0.9% saline (placebo)
Number of subjects: 30
Study 11251702 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g intravenous magnesium sulfate (after placebo)
Number of subjects: 30
Study 9647567 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-culture with human fibroblasts
Number of subjects: 148
Study 9647567 — intervention group
Group type: COMPARATOR
Intervention: Conventional culture
Number of subjects: 148
Study 8005254 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg codeine
Number of subjects: 80
Study 8005254 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg naltrexone
Number of subjects: 80
Study 8005254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 2557184 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevent dentifrice
Number of subjects: 0
Study 2557184 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate TCF
Number of subjects: 0
Study 2557184 — intervention group
Group type: COMPARATOR
Intervention: Crest Tartar Control Formula
Number of subjects: 0
Study 30453682 — intervention group
Group type: EXPERIMENTAL
Intervention: High Glycemic Index meal (HGI)
Number of subjects: 10
Study 30453682 — intervention group
Group type: COMPARATOR
Intervention: Low Glycemic Index meal (LGI)
Number of subjects: 10
Study 28655036 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous BiCIs (2 cochlear implants during 1 surgical procedure)
Number of subjects: 40
Study 28655036 — intervention group
Group type: COMPARATOR
Intervention: Sequential BiCIs (2 cochlear implants with an interval of 2 years between implants)
Number of subjects: 40
Study 25468586 — intervention group
Group type: COMPARATOR
Intervention: No head elevation
Number of subjects: 167
Study 25468586 — intervention group
Group type: EXPERIMENTAL
Intervention: Sniffing position (6.0 cm head elevation)
Number of subjects: 167
Study 25468586 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated sniffing position (10.0 cm head elevation)
Number of subjects: 167
Study 23989945 — intervention group
Group type: EXPERIMENTAL
Intervention: Home treatment
Number of subjects: 97
Study 23989945 — intervention group
Group type: COMPARATOR
Intervention: Combined community locations (home and GP)
Number of subjects: 97
Study 23989945 — intervention group
Group type: COMPARATOR
Intervention: Hospital treatment
Number of subjects: 97
Study 23989945 — intervention group
Group type: COMPARATOR
Intervention: Community treatment (home and GP)
Number of subjects: 97
Study 23989945 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment locations
Number of subjects: 97
Study 23989945 — intervention group
Group type: COMPARATOR
Intervention: GP surgeries
Number of subjects: 97
Study 21928195 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin bolus injection
Number of subjects: 73
Study 21928195 — intervention group
Group type: COMPARATOR
Intervention: Thrombin slow injection
Number of subjects: 73
Study 17940111 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone patches
Number of subjects: 60
Study 17940111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16513420 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD+CRT
Number of subjects: 31
Study 16513420 — intervention group
Group type: COMPARATOR
Intervention: ICD alone
Number of subjects: 31
Study 15081434 — intervention group
Group type: EXPERIMENTAL
Intervention: DCA plus stenting
Number of subjects: 753
Study 15081434 — intervention group
Group type: COMPARATOR
Intervention: Stenting alone
Number of subjects: 753
Study 11544429 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily
Number of subjects: 26
Study 9244018 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal Doppler monitor
Number of subjects: 16
Study 9244018 — intervention group
Group type: COMPARATOR
Intervention: Continuous cardiac output monitor
Number of subjects: 16
Study 8015566 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream
Number of subjects: 100
Study 8015566 — intervention group
Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 100
Study 3552845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg x 2)
Number of subjects: 444
Study 3552845 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (400 mg x 2)
Number of subjects: 444
Study 29809161 — intervention group
Group type: EXPERIMENTAL
Intervention: Becaplermin gel plus good wound care (BGWC)
Number of subjects: 62
Study 29809161 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel plus good wound care (control)
Number of subjects: 62
Study 27296439 — intervention group
Group type: EXPERIMENTAL
Intervention: Fines for nonattendance (intervention arm includes a letter explaining fines for nonattendance)
Number of subjects: 0
Study 27296439 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control arm with no letter attachment)
Number of subjects: 0
Study 27296439 — intervention group
Group type: EXPERIMENTAL
Intervention: Fines for nonattendance
Number of subjects: 0
Study 27296439 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 0
Study 24423298 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of pegvisomant
Number of subjects: 10
Study 24423298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 23539702 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intense pulsed light (IPL) treatment
Number of subjects: 47
Study 23539702 — intervention group
Group type: COMPARATOR
Intervention: Placebo IPL treatment
Number of subjects: 47
Study 19874632 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid yogurt
Number of subjects: 18
Study 19874632 — intervention group
Group type: COMPARATOR
Intervention: Chocolate bars
Number of subjects: 18
Study 17764767 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (HD) group (10^8 cells)
Number of subjects: 60
Study 17764767 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose (LD) group (10^7 cells)
Number of subjects: 60
Study 17764767 — intervention group
Group type: COMPARATOR
Intervention: Control (C) group (no cell transplantation)
Number of subjects: 60
Study 16888455 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant (AO) supplementation
Number of subjects: 16
Study 16888455 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study 12552359 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 300 mg
Number of subjects: 33
Study 12552359 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Amphetamine 20 mg
Number of subjects: 33
Study 12552359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 10986991 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 120
Study 10986991 — intervention group
Group type: COMPARATOR
Intervention: No special treatment
Number of subjects: 120
Study 8971315 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous stimulation of P6 and Li4
Number of subjects: 84
Study 8971315 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (control group)
Number of subjects: 84
Study 1432432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 1432432 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dopamine (2 micrograms/kg per minute)
Number of subjects: 36
Study 1432432 — intervention group
Group type: EXPERIMENTAL
Intervention: High dopamine (5 micrograms/kg per minute)
Number of subjects: 36
Study 1432432 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Placebo, Low dopamine, High dopamine)
Number of subjects: 36
Study 3917900 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cm2 nitroglycerin plaster
Number of subjects: 12
Study 3917900 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 cm2 nitroglycerin plaster
Number of subjects: 12
Study 3917900 — intervention group
Group type: COMPARATOR
Intervention: Placebo (15 cm2 plaster)
Number of subjects: 12
Study 3917900 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm2 nitroglycerin plaster
Number of subjects: 12
Study 31258016 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent mental health screening
Number of subjects: 0
Study 30053413 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 12 weeks
Number of subjects: 12
Study 30053413 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy middle-aged and healthy elderly)
Number of subjects: 12
Study 27296693 — intervention group
Group type: EXPERIMENTAL
Intervention: rTSST-1v (100 ng to 30 μg)
Number of subjects: 46
Study 27296693 — intervention group
Group type: COMPARATOR
Intervention: Al(OH)3 (200 μg, 600 μg, or 1 mg)
Number of subjects: 46
Study 26060452 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise training
Number of subjects: 50
Study 26060452 — intervention group
Group type: COMPARATOR
Intervention: Mild intensity aerobic exercise training
Number of subjects: 50
Study 23447898 — intervention group
Group type: EXPERIMENTAL
Intervention: CXL group (collagen cross-linking)
Number of subjects: 34
Study 23447898 — intervention group
Group type: COMPARATOR
Intervention: No CXL group (control)
Number of subjects: 34
Study 20395895 — intervention group
Group type: COMPARATOR
Intervention: 0 mL saline
Number of subjects: 75
Study 20395895 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL saline
Number of subjects: 75
Study 20395895 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL saline
Number of subjects: 75
Study 20395895 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mL saline
Number of subjects: 75
Study 20395895 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL saline
Number of subjects: 75
Study 18304239 — intervention group
Group type: COMPARATOR
Intervention: Fluoridated toothpaste (1100 ppm) - Group A (positive control)
Number of subjects: 5
Study 18304239 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoridated toothpaste - Group B (negative control)
Number of subjects: 5
Study 18304239 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth Mousse containing CPP-ACP as a toothpaste - Group C
Number of subjects: 5
Study 18304239 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth Mousse containing CPP-ACP as a topical coating - Group D
Number of subjects: 5
Study 18304239 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth Mousse containing CPP-ACP as a topical coating after fluoridated toothpaste - Group E
Number of subjects: 5
Study 16253978 — intervention group
Group type: EXPERIMENTAL
Intervention: OC-scheduled GnRH antagonist (ganirelix)
Number of subjects: 332
Study 16253978 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 332
Study 16253978 — intervention group
Group type: COMPARATOR
Intervention: Non-scheduled GnRH antagonist
Number of subjects: 332
Study 12108857 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg, twice daily via Turbuhaler
Number of subjects: 912
Study 12108857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 912
Study 10540367 — intervention group
Group type: EXPERIMENTAL
Intervention: Double filtration plasmapheresis (DFPP)
Number of subjects: 16
Study 7484629 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging quantification method for estimation of total volumes of subcortical lesions
Number of subjects: 12
Study 7484629 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging quantification method for estimation of ventricular CSF volumes
Number of subjects: 12
Study 7484629 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcortical lesion volume estimation
Number of subjects: 12
Study 7484629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular CSF volume estimation
Number of subjects: 12
Study 1967210 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss plus atenolol
Number of subjects: 692
Study 1967210 — intervention group
Group type: COMPARATOR
Intervention: Usual diet plus chlorthalidone
Number of subjects: 692
Study 1967210 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug plus weight loss groups
Number of subjects: 692
Study 366719 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (5 grain ASA capsules)
Number of subjects: 30
Study 366719 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose placebo)
Number of subjects: 30
Study 30773861 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture of EX-B2
Number of subjects: 40
Study 30773861 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 40
Study 28321638 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (pressures of 26.4 ± 5.3, 17.5 ± 4.4, and 6.1 ± 2.0 mmHg at the ankle, calf, and thigh, respectively)
Number of subjects: 9
Study 28321638 — intervention group
Group type: COMPARATOR
Intervention: Loose‐fitting stockings (Control)
Number of subjects: 9
Study 28321638 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings
Number of subjects: 9
Study 28321638 — intervention group
Group type: COMPARATOR
Intervention: Graduated compression stockings and Control
Number of subjects: 9
Study 25823275 — intervention group
Group type: EXPERIMENTAL
Intervention: Umifenovir 200 mg four times daily for 5 days
Number of subjects: 293
Study 25823275 — intervention group
Group type: COMPARATOR
Intervention: Placebo four times daily for 5 days
Number of subjects: 293
Study 24055306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluzone(®) Intradermal vaccine
Number of subjects: 1250
Study 24055306 — intervention group
Group type: COMPARATOR
Intervention: Fluzone(®) Intramuscular vaccine
Number of subjects: 1250
Study 21865396 — intervention group
Group type: EXPERIMENTAL
Intervention: H5N1 VLP vaccine at 15, 45, or 90 μg HA/dose
Number of subjects: 0